Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination

Vaccine

Volumn 20, Issue 16, 2002, Pages 2022-2026

  Stittelaar, Koert J ^a   De Swart, Rik L ^a   Vos, Helma W ^a   Van Amerongen, Geert ^b   Sixt, Nathalie ^c   Wild, T Fabian ^c   Osterhaus, Albert D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c INSERM   (France)

Author keywords

DNA vaccination; Macaques; Measles

Indexed keywords

DNA VACCINE; MEASLES ANTIBODY; MEASLES VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; MACACA; MEASLES; MEASLES VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION; VIREMIA; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; MACACA FASCICULARIS; MEASLES VACCINE; VACCINATION; VACCINES, DNA;

EID: 0037093635     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00048-8     Document Type: Article

References (23)

1. Measles vaccines, new developments and immunization strategies
2. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components
3. Use of cotton rats for preclinical evaluation of measles vaccines
4. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles vaccine in the presence of passively acquired antibodies
5. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity
6. Early studies on DNA-based immunizations for measles virus
7. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene
8. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin
9. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector
10. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection
11. Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: Involvement of IFNγ
12. Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles
13. Measles virus DNA vaccination: Antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen
14. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
15. Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies in a FACS-measured immunofluorescence assay
16. Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum
17. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies
18. Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination
19. Protective cellular immunity: Cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization
20. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge
21. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge
22. Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: Enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models
23. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis